-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We lower our 12-month target by $30 to $220, based on a 2027 P/E of 7.5x, a justified discount to ABG's 10-year average forward P/E of 8.6x. We lower our adjusted EPS estimates to $26.15 from $28.50 for 2026 and to $29.50 from $31.30 for 2027. ABG's same-store sales remains concerning, with revenue declining 9% Y/Y in Q1, as it continues to feel pressure from broader industry headwinds and consumer spending constraints, and is particularly notable given ABG's favorable geographic footprint concentrated in faster-growing southeastern U.S. markets. While we liked ABG's mid-2025 Herb Chambers acquisition (a top 20 private U.S. auto dealership in terms of annual revenue), the acquired assets weren't enough to offset disappointing same-store sales, driving a $260M top-line shortfall relative to consensus. We remain at Hold, seeing more compelling opportunities across the space.